Celcuity (CELC) Other Non Operating Income (2020 - 2024)
Celcuity (CELC) posted Other Non Operating Income of -$728756.0 for Q4 2024, down 371.81% on a QoQ basis from $268110.0 in Q3 2024, and up 32.92% year-over-year from -$548262.4 in Q1 2024.
Celcuity (CELC) Other Non Operating Income (2020 - 2024) Analysis & Trends
Celcuity's Other Non Operating Income history runs 5 years deep, the most recent figure standing at -$728756.0 for Q4 2024.
- Quarterly Other Non Operating Income rose 32.92% year-over-year to -$728756.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $982000.0 (up 102.89% YoY) and the FY2025 annual result came in at $1.4 million, up 38.29% from the prior year.
- Other Non Operating Income was -$728756.0 for Q4 2024 at Celcuity, down from $268110.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $881380.0 in Q1 2024 and bottomed at -$1.1 million in Q4 2023.
- A 5-year average of -$39164.6 and a median of $443.0 in 2020 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2022 — Other Non Operating Income slumped 418572.55% — and 2023, when it soared 297.27%.
- Celcuity's Other Non Operating Income stood at $443.0 in 2020, then slumped by 97754.18% to -$432608.0 in 2021, then soared by 113.37% to $57858.0 in 2022, then sank by 1977.73% to -$1.1 million in 2023, then surged by 32.92% to -$728756.0 in 2024.
- Business Quant data shows CELC's Other Non Operating Income at -$728756.0 in Q4 2024, $268110.0 in Q3 2024, and $561266.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Celcuity | 4.13 Bn | 4.13 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -728,756.00 |
| Sep 30, 2024 | 268,110.00 |
| Jun 30, 2024 | 561,266.00 |
| Mar 31, 2024 | 881,380.00 |
| Dec 31, 2023 | -1.09 Mn |
| Sep 30, 2023 | 493,497.00 |
| Jun 30, 2023 | 467,798.00 |
| Mar 31, 2023 | 609,120.00 |
| Dec 31, 2022 | 57,858.00 |
| Sep 30, 2022 | -250,166.00 |
| Jun 30, 2022 | -359,799.00 |
| Mar 31, 2022 | -426,842.00 |
| Dec 31, 2021 | -432,608.00 |
| Sep 30, 2021 | -427,460.00 |
| Jun 30, 2021 | -389,384.00 |
| Mar 31, 2021 | 102.00 |
| Dec 31, 2020 | 443.00 |
| Sep 30, 2020 | 5,777.00 |
| Jun 30, 2020 | 11,952.00 |